Skip to main content
Equibles

Graham Capital Management, L.P.

Position in ZNTL — Zentalis Pharmaceuticals, Inc.

CIK 1315421 ROWAYTON, CT
Back to ZNTL Full portfolio

Position in ZNTL

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$108,436
-$107,843 QoQ
Shares Held
22,358
-75.8% QoQ
Ownership
0.031%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#75
of 114 holders
Holding Since
Sep 2023
10 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in ZNTL Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Graham Capital Management, L.P. holds $44,243,780 across 71 Biotechnology names. ZNTL ranks #50 (0.2% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 TVTX
Travere Therapeutics, Inc.
 446,696 $25,376,799
2 INCY
Incyte Corp
 15,632 $1,772,043
3 IONS
Ionis Pharmaceuticals Inc
 16,717 $1,325,490
4 VKTX
Viking Therapeutics, Inc.
 22,114 $862,667
5 ALNY
Alnylam Pharmaceuticals, Inc.
 2,256 $679,123
6 ARVN
Arvinas, Inc.
 81,364 $676,134
7 PCVX
Vaxcyte, Inc.
 11,107 $645,649
8 MRVI
Maravai Lifesciences Holdings, Inc.
 92,277 $575,808

All Filings in ZNTL

Export CSV
10 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $108,436 22,358
2026-03-31 $216,279 92,427
2025-12-31 $122,728 90,910
2025-09-30 $229,741 152,147
2025-06-30 $41,151 35,475
2025-03-31 $198,433 124,801
2024-12-31 $175,576 57,946
2024-09-30 $155,244 42,186
2024-06-30 $46,891 11,465
2023-09-30 $212,636 10,600